-
Founded in:
1990-02-24 -
Country:
China -
Address:
No. 1-6, 23F, Building 1, No. 160, Qiaokou Road, Qiaokou District, Wuhan City, Hubei Province -
Tax NO.:
91420100707162257C -
Registered Funds:
2351.254765 yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metamizole Sodium Monohydrate |
The antipyretic and analgesic effects are faster and stronger than those of aminopyrine.
More
The antipyretic and analgesic effects are faster and stronger than those of aminopyrine. |
5907-38-0 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetylsalicylic acid |
Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation
More
Analgesic, anti-inflammatory, antipyretic, anti-rheumatic, inhibiting platelet aggregation |
50-78-2 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 5-Fluorouracil |
Extract from the above information
More
Extract from the above information |
51-21-8 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Trimetazidine dihydrochloride |
By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. Animal studies have shown that it can help maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduce intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduce the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, reduce the scope of experimental infarction, and have no significant effect on hemodynamics. Human studies have shown that it can increase coronary blood flow reserve, delay the occurrence of exercise-induced ischemia, limit rapid fluctuations in blood pressure without significant changes in heart rate, reduce the frequency of angina attacks, and reduce the use of glyceryl trinitrate.
More
By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. Animal studies have shown that it can help maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduce intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduce the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, reduce the scope of experimental infarction, and have no significant effect on hemodynamics. Human studies have shown that it can increase coronary blood flow reserve, delay the occurrence of exercise-induced ischemia, limit rapid fluctuations in blood pressure without significant changes in heart rate, reduce the frequency of angina attacks, and reduce the use of glyceryl trinitrate. |
13171-25-0 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tiapride hydrochloride |
This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect.
More
This product belongs to the benzamide antipsychotic drug, which has an inhibitory effect on the hyperfunction of dopaminergic nerves in the midbrain limbic system and an antagonistic effect on dopaminergic nerve movement disorders in the striatum, thereby producing a calming and sedative effect. It is characterized by its good effect on sensory and motor neurological diseases and psychomotor behavioral disorders. Animal experiments have confirmed that this product can block the conduction of pain impulses through the spinal thalamic tract to the reticular formation. The analgesic effect of this drug may be related to the integration of pain impulses by the thalamus. In addition, it has an antiemetic effect. |
51012-33-0 | 12 |